Pfizer Products India Profile
Key Indicators
- Authorised Capital ₹ 17.50 Cr
- Paid Up Capital ₹ 17.50 Cr
- Company Age 28 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.11 Cr
- Revenue Growth -12.25%
- Profit Growth -26.69%
- Ebitda -29.25%
- Net Worth 12.19%
- Total Assets 18.68%
About Pfizer Products India
Pfizer Products India Private Limited (PPIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 19 December 1996 and has a history of 28 years and one month. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Pharmacia India Private Limited. The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 17.50 Cr and a paid-up capital of Rs 17.50 Cr.
The company currently has active open charges totaling ₹1.11 Cr.
The Key Managerial Personnel (KMP) at Pfizer Products India Private Limited India is Swapna Soman as COMPANY SECRETARY. Darshak Bhagat, Seema Pai, Murtuza Darukhanawala, and One other member serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24230MH1996FTC148003
-
Company No.
148003
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
19 Dec 1996
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Pfizer Products India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swapna Soman | Company Secretary | 28-Sep-2024 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murtuza Darukhanawala
|
Whole-Time Director | 14-May-2021 | Current |
|
Darshak Bhagat
|
Director | 31-Mar-2021 | Current |
|
Seema Pai
|
Whole-Time Director | 25-Sep-2020 | Current |
|
Shabbar Vhora
|
Whole-Time Director | 14-May-2021 | Current |
Financial Performance of Pfizer Products India.
Pfizer Products India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.25% decrease. The company also saw a substantial fall in profitability, with a 26.69% decrease in profit. The company's net worth Soared by an impressive increase of 12.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pfizer Products India?
In 2023, Pfizer Products India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Wyeth Pharmaceuticals India Private LimitedDarshak Bhagat is a mutual person
Charges (Loans)
₹1.11 Cr
₹0
Charges Breakdown by Lending Institutions
- Corproation Bank : 1.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jun 2002 | Corproation Bank | ₹0.35 M | Open |
| 17 May 2002 | Corproation Bank | ₹0.35 M | Open |
| 28 Aug 2001 | Corproation Bank | ₹6.00 M | Open |
| 25 Jun 2001 | Corproation Bank | ₹0.25 M | Open |
| 19 Jun 2001 | Corproation Bank | ₹0.62 M | Open |
How Many Employees Work at Pfizer Products India?
Pfizer Products India has a workforce of 279 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pfizer Products India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pfizer Products India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
